Core Viewpoint - A class action lawsuit has been filed against Agilon Health, Inc. for alleged violations of securities laws, specifically related to misleading statements made by the company regarding its financial guidance and strategic actions [1][4]. Group 1: Lawsuit Details - The lawsuit is based on violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 [1]. - Investors who purchased Agilon's securities between February 26, 2025, and August 4, 2025, are encouraged to participate in the lawsuit [2]. - The class has not yet been certified, meaning potential participants are not currently represented by an attorney [3]. Group 2: Allegations Against Agilon - The complaint alleges that Agilon made false and misleading statements to the market, particularly regarding its 2026 guidance, which was deemed unrealistic [4]. - The company is accused of overstating the effectiveness of its strategic actions aimed at reducing risk, leading to materially misleading public statements throughout the class period [4]. - As a result of the revelations about Agilon's true situation, investors reportedly suffered financial damages [4].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of agilon health, inc. securities for the period between February 26, 2025, and August 4, 2025, due to alleged misleading statements and guidance by the company [1][5]. Group 1: Lawsuit Details - The lawsuit claims that defendants made false and/or misleading statements regarding agilon's financial guidance for 2025, which they knew or should have known was unattainable due to industry challenges [5]. - It is alleged that the defendants overstated the positive financial impact from strategic actions taken by agilon to mitigate risks, leading to materially false statements about the company's business and prospects [5]. - Investors are encouraged to join the class action, which allows them to seek compensation without upfront costs through a contingency fee arrangement [2][3]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering significant amounts for investors [4]. - The firm has been recognized for its performance in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 and securing over $438 million for investors in 2019 [4]. - Investors can join the class action by submitting a form or contacting the firm directly for more information [3][6].

Core Viewpoint - A securities fraud lawsuit has been filed against agilon health, inc. following a significant drop in its stock price due to the resignation of its CEO and the withdrawal of its financial guidance for 2025 [1][2]. Group 1: Company Developments - Shares of agilon health, Inc. fell more than 25% in after-hours trading on August 4, 2025, after the announcement of CEO Steven Sell's immediate resignation and the withdrawal of the full-year 2025 financial guidance [2]. - The company cited unexpected medical cost pressures and downward adjustments to prior revenue estimates as reasons for these actions [2]. Group 2: Allegations in the Lawsuit - The complaint alleges that agilon recklessly issued guidance for 2025 that they knew or should have known was unattainable due to material industry headwinds [3]. - It is claimed that agilon materially overstated the immediate positive financial impact from strategic actions taken to reduce risk, leading to materially false and/or misleading statements about the company's business and prospects [3]. Group 3: Investor Information - Investors who purchased agilon health, inc. common stock between February 26, 2025, and August 4, 2025, and have experienced a loss may be eligible to participate in the lawsuit [4]. - The deadline to seek appointment as lead plaintiff is March 2, 2026, and a class has not yet been certified [5]. Group 4: Whistleblower Information - Individuals with non-public information about agilon health, inc. are encouraged to assist in the investigation or file a report with the SEC under the whistleblower program, potentially receiving rewards of up to 30% of any successful recovery [6]. Group 5: Legal Representation - Block & Leviton is recognized as a leading securities class action firm, having recovered billions for defrauded investors and representing many top institutional investors [7].

Core Viewpoint - A class action lawsuit has been filed against agilon health, inc. and certain officers for alleged violations of federal securities laws during the Class Period from February 26, 2025, to August 4, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for all individuals and entities that purchased or acquired agilon securities during the specified Class Period [2]. - Defendants are accused of making false or misleading statements and failing to disclose critical information regarding agilon's business and financial outlook [3][8]. - Investors who suffered losses in agilon have until March 2, 2026, to request to be appointed as lead plaintiff in the case [3]. Group 2: Allegations Against Defendants - Defendants allegedly issued guidance for 2026 that was unrealistic given known industry challenges [8]. - There were claims that the financial impact from "strategic actions" taken by agilon to mitigate risks was materially overstated [8]. - Overall, the statements made by defendants regarding agilon's business operations and prospects were deemed materially false or misleading throughout the Class Period [8]. Group 3: Legal Representation - Bronstein, Gewirtz & Grossman, LLC represents investors on a contingency fee basis, meaning they will only collect fees if the case is successful [4]. - The firm has a history of recovering significant amounts for investors in securities fraud cases [5].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of agilon health, inc. securities between February 26, 2025, and August 4, 2025, due to alleged misleading statements and guidance by the company [1][5]. Group 1: Lawsuit Details - The lawsuit claims that defendants made false and/or misleading statements regarding agilon's financial guidance for 2025, which they knew was unattainable due to industry challenges [5]. - It is alleged that the defendants overstated the positive financial impact from strategic actions taken by agilon to mitigate risks, leading to materially false statements about the company's business and prospects [5]. - Investors are encouraged to join the class action without incurring out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Participation Information - Interested parties can join the agilon class action by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must file a motion with the court by March 2, 2026, to represent other class members in the litigation [3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its success in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [4].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of agilon health, inc. securities for the period between February 26, 2025, and August 4, 2025, due to alleged misleading statements and guidance by the company [1][5]. Group 1: Lawsuit Details - The lawsuit claims that defendants made false and/or misleading statements regarding agilon's financial guidance for 2025, which they knew or should have known was unattainable due to industry challenges [5]. - It is alleged that defendants overstated the positive financial impact from strategic actions taken by agilon to mitigate risks, leading to materially false statements about the company's business and prospects [5]. - Investors are encouraged to join the class action to seek compensation without upfront costs through a contingency fee arrangement [2][3]. Group 2: Participation Information - Interested parties can join the agilon class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by March 2, 2026, to represent other class members in the litigation [1][3]. - No class has been certified yet, and investors can choose to remain absent or select their own counsel [7]. Group 3: Rosen Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

NEW YORK--(BUSINESS WIRE)--Third paragraph, first sentence of release should read: (1) Defendants recklessly issued guidance for 2025 that they knew or should have known was not going to be achieved ...

Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who acquired Agilon Health, Inc. (NYSE: AGL) securities between February 26, 2025, and August 4, 2025, alleging that the company misled investors regarding its business prospects [1] Allegations - The complaint asserts that Agilon Health, Inc. failed to disclose that it issued guidance for 2025 that was unrealistic, given the material industry challenges they were aware of, and that they materially overstated the financial benefits from strategic actions taken to mitigate risks [2] Company Developments - On August 4, 2025, Agilon announced the resignation of Steven Sell as President, CEO, and Director, stating that his departure was a termination without 'cause' according to his employment agreement. The same day, the company released disappointing financial results, leading to a stock price drop of over 50%, closing at $0.8801 on August 5, 2025 [3] Class Action Participation - Shareholders may be eligible to participate in the class action against Agilon Health, Inc. Those interested in serving as lead plaintiffs should contact Robbins LLP. Participation is not required to be eligible for recovery, and shareholders can choose to remain absent class members [4]

Core Viewpoint - A class action lawsuit has been filed against agilon health, inc. for securities purchased between February 26, 2025, and August 4, 2025, seeking to recover damages for investors under federal securities laws [1] Company Summary - The lawsuit is initiated by Rosen Law Firm, which specializes in investor rights [1] - The class action is aimed at purchasers of agilon health, inc. securities during the specified class period [1] Legal Context - The lawsuit seeks to hold agilon health accountable under federal securities laws for potential damages incurred by investors [1]

Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of Agilon Health, Inc. (NYSE: AGL) towards shareholders [1] Group 1: Legal Actions and Shareholder Rights - Long-term shareholders of Agilon may seek corporate governance reforms, return of funds, court-approved financial incentives, or other benefits [2] - Shareholder involvement is crucial for improving company policies and practices, leading to enhanced shareholder value [3] Group 2: Firm's Background and Services - Halper Sadeh LLC represents global investors affected by securities fraud and corporate misconduct, having recovered millions for defrauded investors [4]